Frequently Asked Questions about Vycor Medical, Inc. (VYCO)

Name: Vycor Medical, Inc. (VYCO) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Vycor Medical, Inc. (VYCO) do?

Accepted Answer

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction ...

Question 2

Is Vycor Medical, Inc. (VYCO) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of VYCO reveals an Altman Z-Score of -60.69 and a Piotroski F-Score of 3/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if VYCO fits their risk profile.

Question 3

What is the current P/E ratio for VYCO?

Accepted Answer

As of the latest trading session, Vycor Medical, Inc. (VYCO) has a trailing P/E ratio of -41.47.

Question 4

Who is the CEO of Vycor Medical, Inc.?

Accepted Answer

The current Chief Executive Officer of Vycor Medical, Inc. is Peter C. Zachariou.

Question 5

What was VYCO's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Vycor Medical, Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does VYCO pay a dividend?

Accepted Answer

Vycor Medical, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does VYCO have?

Accepted Answer

In its latest reporting period, Vycor Medical, Inc. generated $-0.00B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Vycor Medical, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Vycor Medical, Inc. (VYCO) is currently -0.73.

Question 9

What is the Price-to-Sales (P/S) ratio of VYCO?

Accepted Answer

Based on trailing twelve-month data, Vycor Medical, Inc. (VYCO) trades at a Price-to-Sales (P/S) ratio of 1.61.

Question 10

What is Vycor Medical, Inc.'s Return on Equity (ROE)?

Accepted Answer

Vycor Medical, Inc. (VYCO) has a Return on Equity (ROE) of 1.83%, representing its profitability relative to shareholder equity.